SUVOREXANT
UNII 081L192FO9

Substance Identification & Data

This profile provides standardized clinical and technical data for Suvorexant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 081L192FO9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1030377-33-3 and the RxNorm Concept ID (RxCUI) 1547099. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

081L192FO9

CAS Registry Number

1030377-33-3

RxNorm Concept ID

1547099

Detailed Substance Profile

Preferred Name

SUVOREXANT

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

081L192FO9

The specific atomic composition represented as a molecular structure string.

InChIKey

C23H23ClN6O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JYTNQNCOQXFQPK-MRXNPFEDSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C171858

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

24965990

Unique identification number in the NCBI database of chemical substances.

INN ID

9435

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-119

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

n1(nccn1)-c2c(cc(cc2)C)C(=O)N3CCN(c4oc5c(n4)cc(cc5)Cl)CC[C@H]3C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Suvorexant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.